Use of the acute bronchitis symptom severity (ABSS) scale across language versions in the MOSAIC trial

L. Frank, M. K. Margolis, N. Amiot, I. Duprat-Lomon, P. P. Sagnier (Bethesda, United States Of America; Puteaux, France; Stoke Poges, United Kingdom)

Source: Annual Congress 2003 - COPD in primary care
Session: COPD in primary care
Session type: Thematic Poster Session
Number: 528
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
L. Frank, M. K. Margolis, N. Amiot, I. Duprat-Lomon, P. P. Sagnier (Bethesda, United States Of America; Puteaux, France; Stoke Poges, United Kingdom). Use of the acute bronchitis symptom severity (ABSS) scale across language versions in the MOSAIC trial. Eur Respir J 2003; 22: Suppl. 45, 528

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
COPD eDiary compliance: Comparison of age, symptom score, duration in clinical trial and country of origin
Source: Annual Congress 2010 - Risk factors, prevalence and consequences of COPD
Year: 2010


An acute bronchitis questionnaire (AECB-SS) discriminates between GOLD categories for COPD severity in patients screened for the MOSAIC study
Source: Eur Respir J 2004; 24: Suppl. 48, 239s
Year: 2004

Development and validation of an innovative self-administered computerized (SAC) version of baseline/transition dyspnea index (BDI/TDI) for evaluating breathlessness in patients with COPD: The BLAZE study
Source: Annual Congress 2013 –Novel pharmacological findings in the management of respiratory disorders
Year: 2013


The Cough Severity Diary in a pooled analysis of two, phase 3 trials of gefapixant in chronic cough
Source: Virtual Congress 2021 – Exacerbations of chronic respiratory diseases, including SARS-CoV-2
Year: 2021



A randomised controlled trial of cognitive behavioural therapy (CBT) delivered by respiratory nurses to reduce anxiety in chronic obstructive pulmonary disease (COPD). (Trial registration - ISCRCTN55206395)
Source: International Congress 2016 – Respiratory nursing research: opening new perspectives on patient experiences
Year: 2016


Change in clinical COPD questionnaire (CCQ) symptoms domain score and FEV1 predict treatment failure during hospitalisation due to COPD exacerbations
Source: Eur Respir J 2007; 30: Suppl. 51, 525s
Year: 2007

Portuguese version of the modified pulmonary functional status and dyspnea questionnaire (PFSDQ-M) and the Medical Research Council scale (MRC) in patients with chronic obstructive pulmonary disease: a validation study
Source: Annual Congress 2008 - Respiratory mechanics, muscles and breathing; functional status measures and coping styles
Year: 2008


Development and pilot testing of a new 7-item cough severity patient reported outcome measure
Source: Annual Congress 2008 - COPD epidemiology
Year: 2008


Quality of life in home ventilation (HMV): Validation of the English version of severe respiratory insufficiency (SRI) questionnaire
Source: Annual Congress 2010 - From the acute to the chronic patient: how do we use noninvasive ventilation?
Year: 2010


The bronchitis severity scale (BSS): A validated tool to assess the effect of pharmacotherapy in acute bronchitis
Source: International Congress 2015 – Healthcare organisation and appropriateness in lung disorders
Year: 2015


Hindi version of chronic respiratory disease questionnaire (CRQ) in Indian patients with chronic obstructive pulmonary disease (COPD): validity and reliability issues
Source: Annual Congress 2008 - Quality of life and mood disturbances in rehabilitation
Year: 2008

Comparison of diagnostic value of patient health questionnaire 9 (PHQ-9) and Beck depression inventory (BDI) questionnaire for preliminary diagnosing of depression in COPD patients (pts)
Source: International Congress 2014 – COPD markers
Year: 2014


Quality of life, clinical severity and symptom severity in COPD patients
Source: Eur Respir J 2004; 24: Suppl. 48, 142s
Year: 2004

Development of the morning activities and symptoms questionnaire (MASQ) for COPD
Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of pulmonary diseases II
Year: 2008

Validity and reliability of the symptom domain of the clinical COPD questionnaire (CCQ)
Source: Eur Respir J 2006; 28: Suppl. 50, 807s
Year: 2006

Depression in chronic obstructive pulmonary disease: Predictors and accuracy of the hospital anxiety and depression scale (HADS)
Source: International Congress 2014 – Latest insights in chronic care
Year: 2014

Pneumonia severity assessment scores in COVID19 pneumonia; clinical validation in a pragmatic healthcare setting
Source: Virtual Congress 2021 – COVID - 19: lessons learned
Year: 2021


Baseline symptom scores and future risk of severe exacerbation: The SPARK study
Source: International Congress 2015 – New data on established treatments for asthma and COPD
Year: 2015


Use of the AQ 20 Airway Questionnaire to detect changes in quality of life (QOL) following a hospital admission for acute asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 45s
Year: 2005

The Leicester Cough Questionnaire in two phase 3 trials of gefapixant in chronic cough
Source: Virtual Congress 2021 – Patient-reported outcome measures (PROMs): easy tools in the management of chronic respiratory diseases
Year: 2021